Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $1.33
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Mar 31, 26 |
Daily · Wilder smoothing
| D. Boral Capital |
| maintain |
| Buy |
| Buy |
| Mar 26, 26 | D. Boral Capital | maintain | Buy | Buy |
| Mar 23, 26 | D. Boral Capital | maintain | Buy | Buy |
| Feb 10, 26 | HC Wainwright & Co. | maintain | Buy | Buy |
| Feb 9, 26 | D. Boral Capital | maintain | Buy | Buy |
| Jan 6, 26 | D. Boral Capital | maintain | Buy | Buy |
| Dec 19, 25 | HC Wainwright & Co. | maintain | Buy | Buy |
| Dec 19, 25 | D. Boral Capital | maintain | Buy | Buy |
| Dec 15, 25 | D. Boral Capital | maintain | Buy | Buy |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 23.01 | Oscillator | Buy |
| Stochastic %K (14, 3, 3) | 31.81 | Oscillator | Neutral |
| Williams %R (14) | -66.67 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.29 (Hist 0.02) | Oscillator | Buy |
| Average Directional Index (14) | 56.71 (+DI 9.0 / -DI 41.6) | Trend | Strong Sell |
| EMA 20 | 1.63 | MA | Strong Sell |
| SMA 20 | 1.61 | MA | Strong Sell |
| EMA 50 | 2.09 | MA | Strong Sell |
| SMA 50 | 2.34 | MA | Strong Sell |
| SMA 200 | 3.17 | MA | Strong Sell |
TTM vs. 5-year historical average (annual ratios)
| Metric | AVXL | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -5.1x | -17.6x · sector 20.7x | Discount |
| Forward P/E (FY26E) | -4.0x | EPS est. -0.33 | Discount |
| Price / Book | 1.1x | 5.9x | Discount |
| Price / Sales | — | — | n/a |
| EV / EBITDA | -0.2x | -14.6x | Discount |
| Return on equity | -21.1% | — | Weak |
| Gross margin | 0.0% | 0.0% | n/a |
| Debt / Equity | 0.00 | 0.00 | Conservative |
| Piotroski / Altman Z | 1/9 | Z 5.86 | Safe zone |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 8-K | Oct 20, 2026 | 2026-10-20 16:16:06 | View |
| 8-K | Oct 15, 2026 | 2026-10-15 16:18:27 | View |
| 3 | Oct 5, 2026 | 2026-10-05 17:00:35 | View |
| 3 | Oct 5, 2026 | 2026-10-05 16:05:26 | View |
| 4 | Sep 28, 2026 | 2026-09-28 21:36:32 | View |
| 8-K | Sep 28, 2026 | 2026-09-28 17:27:47 | View |
| DFAN14A | Sep 21, 2026 | 2026-09-18 19:05:17 | View |
| DFAN14A | Sep 18, 2026 | 2026-09-18 16:10:03 | View |
| DFAN14A | Sep 17, 2026 | 2026-09-17 12:54:12 | View |
| DEFA14A | Sep 15, 2026 | 2026-09-15 17:15:49 | View |
Proxy statement (DEF 14A) disclosures
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 24, 26 | Senderowicz Adrian | director: | 0 | — | |
| Sep 24, 26 | Patel Gautam | director: | 0 | — | |
| Sep 24, 26 | Boenisch Sandra | officer: PFO & Treasurer | A-Award | 25,000 @ $8.57 | $214.3K |
| Sep 24, 26 | Boenisch Sandra | officer: PFO & Treasurer | A-Award | 25,000 @ $5.36 | $134.0K |
| Sep 24, 26 | Boenisch Sandra | officer: PFO & Treasurer | A-Award | 25,000 @ $8.58 | $214.5K |
| Sep 24, 26 | Boenisch Sandra | officer: PFO & Treasurer | A-Award | 20,000 @ $10.09 | $201.8K |
| May 4, 26 | Kellmeyer Terrie | officer: Interim CEO | 50,000 @ $8.58 | $429.0K | |
| May 4, 26 | Kellmeyer Terrie | officer: Interim CEO | 46,668 @ $7.21 | $336.5K |
Stock news · updated daily
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 24, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
New York, New York--(Newsfile Corp. - October 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Suit alleges Anavex Life Sciences Corp. failed to disclose key facts to investors from November 26, 2025 through August 28, 2026; lead plaintiff deadline is November 30, 2026 BENSALEM TOWNSHIP, Pa., Oct. 23, 2026 /PRNewswire/ -- The Law Offices of Howard G.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 23, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
New York, New York--(Newsfile Corp. - October 23, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Anavex and have suffered losses, you may CLICK HERE to contact us.
New York, New York--(Newsfile Corp. - October 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What Should Anavex Life Sciences Corp. Investors Know After 6.35% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plain
Lawsuit alleges Anavex Life Sciences Corp. made misleading statements to investors from November 26, 2025 to August 28, 2026; lead plaintiff motions are due November 30, 2026 LOS ANGELES, Oct. 22, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz today announced a class action lawsuit against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors who acquired the Company's securities from November 26, 2025 to August 28, 2026.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 28, 2026 | -0.08 | -0.03 | Beat 62.5% | — |
| Aug 25, 2026 | -0.08 | 0.08 | Beat 200.0% | — |
| Feb 9, 2026 | -0.10 | -0.06 | Beat 40.0% | — |
| Nov 25, 2025 | -0.13 | -0.11 | Beat 15.4% | — |
| Aug 12, 2025 | -0.13 | -0.16 | Miss -23.1% | — |
| May 13, 2025 | -0.16 | -0.13 | Beat 18.8% | — |